DK0984934T3 - Hidtil ukendte oralt aktive jern(III)chelateringsmidler - Google Patents

Hidtil ukendte oralt aktive jern(III)chelateringsmidler

Info

Publication number
DK0984934T3
DK0984934T3 DK98922968T DK98922968T DK0984934T3 DK 0984934 T3 DK0984934 T3 DK 0984934T3 DK 98922968 T DK98922968 T DK 98922968T DK 98922968 T DK98922968 T DK 98922968T DK 0984934 T3 DK0984934 T3 DK 0984934T3
Authority
DK
Denmark
Prior art keywords
hydrogen
aryl
group
aralkyl
alkyl
Prior art date
Application number
DK98922968T
Other languages
Danish (da)
English (en)
Inventor
Robert Charles Hider
Gary Stuart Tilbrook
Zudong Liu
Original Assignee
Btg Internat Ltd Company No 26
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Internat Ltd Company No 26 filed Critical Btg Internat Ltd Company No 26
Application granted granted Critical
Publication of DK0984934T3 publication Critical patent/DK0984934T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98922968T 1997-05-29 1998-05-26 Hidtil ukendte oralt aktive jern(III)chelateringsmidler DK0984934T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711093.6A GB9711093D0 (en) 1997-05-29 1997-05-29 Novel orally active iron (III) chelators
PCT/GB1998/001517 WO1998054138A1 (en) 1997-05-29 1998-05-26 Novel orally active iron (iii) chelators

Publications (1)

Publication Number Publication Date
DK0984934T3 true DK0984934T3 (da) 2003-05-05

Family

ID=10813233

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98922968T DK0984934T3 (da) 1997-05-29 1998-05-26 Hidtil ukendte oralt aktive jern(III)chelateringsmidler

Country Status (12)

Country Link
US (2) US6335353B1 (de)
EP (1) EP0984934B1 (de)
JP (1) JP2002500663A (de)
AT (1) ATE230728T1 (de)
AU (1) AU751600B2 (de)
CA (1) CA2287907C (de)
DE (1) DE69810619T2 (de)
DK (1) DK0984934T3 (de)
ES (1) ES2187025T3 (de)
GB (1) GB9711093D0 (de)
WO (1) WO1998054138A1 (de)
ZA (1) ZA984635B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1220870B1 (de) 1999-10-01 2012-04-11 DMI Biosciences, Inc. Metall bindende verbindungen und ihre verwendungen
US6426418B1 (en) 2001-11-02 2002-07-30 Apotex, Inc. Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
WO2003065991A2 (en) 2002-02-05 2003-08-14 Bristol-Myers Squibb Company N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
US8058442B2 (en) 2002-11-07 2011-11-15 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
NZ529657A (en) * 2003-11-20 2004-07-30 Apotex Inc Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones
CA2488034C (en) * 2004-11-19 2009-10-06 Apotex Inc. Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
GB0506677D0 (en) * 2005-04-01 2005-05-11 Btg Int Ltd Iron modulators
TWI404533B (zh) * 2007-03-28 2013-08-11 Apotex Technologies Inc 去鐵酮(deferiprone)之氟化衍生物
GB0803019D0 (en) * 2008-02-19 2008-03-26 Btg Int Ltd Fluorinated compounds
UA102254C2 (ru) 2008-04-25 2013-06-25 Апотекс Технолоджис Инк. Жидкий состав для деферипрона с приятным вкусом
KR101695807B1 (ko) 2008-07-25 2017-01-13 비이브 헬쓰케어 컴퍼니 화합물
ES2964383T3 (es) 2008-12-11 2024-04-05 Viiv Healthcare Co Procesos e intermedios para inhibidores de la integrasa del VIH de carbamoilpiridona
MX2011006241A (es) 2008-12-11 2011-06-28 Shionogi & Co Sintesis de inhibidores de integrasa de vih de carbamoil-piridona e intermediarios.
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
CN102712591B (zh) 2009-07-03 2014-06-25 阿普泰克斯科技公司 3-羟基吡啶-4-酮的氟化衍生物
TWI582097B (zh) 2010-03-23 2017-05-11 Viiv醫療保健公司 製備胺甲醯吡啶酮衍生物及中間體之方法
CN109438405B (zh) * 2018-12-24 2023-04-07 广东莱佛士制药技术有限公司 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法
WO2020132820A1 (zh) * 2018-12-24 2020-07-02 广东莱佛士制药技术有限公司 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法
CN111606879A (zh) * 2020-05-25 2020-09-01 安徽金禾实业股份有限公司 一锅法制备2-羟甲基-3-烷氧基-4h-吡喃-4-酮的方法
CN113121423B (zh) * 2021-03-10 2022-07-22 浙江工业大学 Ala杂合3-羟基吡啶酮衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518098A1 (de) * 1963-09-19 1969-04-10 Pfizer & Co C Verfahren zur Herstellung von Pyromekonsaeurederivaten
US3468915A (en) * 1966-04-18 1969-09-23 Pfizer & Co C Novel 2-substituted-6-methylpyromeconic acids
JPS5921954B2 (ja) * 1980-02-13 1984-05-23 新日本製鐵株式会社 鋼材の防錆処理方法
US5112968A (en) * 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
DE59611243D1 (de) * 1995-09-29 2005-08-11 Novartis Ag Hydroxypyridinone

Also Published As

Publication number Publication date
US6506911B2 (en) 2003-01-14
US20020068758A1 (en) 2002-06-06
CA2287907A1 (en) 1998-12-03
DE69810619D1 (de) 2003-02-13
DE69810619T2 (de) 2003-09-25
US6335353B1 (en) 2002-01-01
EP0984934A1 (de) 2000-03-15
CA2287907C (en) 2009-01-13
ATE230728T1 (de) 2003-01-15
EP0984934B1 (de) 2003-01-08
AU751600B2 (en) 2002-08-22
ZA984635B (en) 1999-11-29
AU7542798A (en) 1998-12-30
JP2002500663A (ja) 2002-01-08
GB9711093D0 (en) 1997-07-23
ES2187025T3 (es) 2003-05-16
WO1998054138A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
DK0984934T3 (da) Hidtil ukendte oralt aktive jern(III)chelateringsmidler
NZ332363A (en) substituted 4-hydroxy-isoquinoline-3carboxamide derivatives and medicaments
UA39869C2 (uk) Похідні аспартаму або їх фізіологічно прийнятні солі, спосіб їх отримання та підсолоджувальна композиція
DE3275295D1 (en) Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them
ES477457A1 (es) Procedimiento de preparacion de amidas de alcohilendiaminas.
ES8103734A1 (es) Procedimiento para preparar nuevos derivados de piperidina
ES8405364A1 (es) Metodo de preparar amidoaminoacidos n-substituidos.
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
ES8207156A1 (es) Procedimiento para la preparacion de nuevas pirimidinonas .
ES2172093T3 (es) Nuevas composiciones cosmeticas que comprenden un polimero filmogeno.
GR3031517T3 (en) RARy-specific retinobenzoic acid derivatives
ES8605506A1 (es) Procedimiento para preparar derivados de piperidina
FI810389L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
ATE28187T1 (de) Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung.
ES8607218A1 (es) Un procedimiento para preparar compuestos de amidina
ZA816259B (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
ES457001A1 (es) Un procedimiento de preparacion de derivados de fenetilamina.
ES8404976A1 (es) Procedimiento para preparar nuevos derivados de encefalina.
IE792300L (en) 2,4, 6-triiodoisophthalamic acid derivatives; x-ray¹contrast agents
ES8301895A1 (es) "procedimiento para preparar nuevos acidos 2-amino-3-(halobenzoil)-metilfenilaceticos,sus esteres y sus sales metalicas".
IL67023A (en) Substituted thiazolidinyl esters of phosphoric and sulfuric acid
ATE206431T1 (de) Antifungal fusacandine
ES8608873A1 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-piridiln-furilmetil propilaminas.
ES476713A1 (es) Procedimiento para la preparacion de derivados del acido carboxilico de 1,5-ciclohexadieno sustituido.
ES8302734A1 (es) Procedimiento para preparar 5'-n-(aminoalquil)-amino-5'-deo-xiadenosina